Developer docs
API playgroundTry for free, no card

Search company profiles

Uscom

Full company profile

uuid0037bcl

Namestring
Uscom
Legal namestring
Uscom Limited
Websiteurl
uscom.com.au
Company typeenum
Public
Founded yearint
1999
Descriptiontext

Uscom Limited (ASX: UCM) is an Australian medical technology company founded in 1999 and headquartered in Sydney that develops, manufactures, and globally markets non-invasive cardiovascular and pulmonary monitoring devices. The company's three core product suites are the USCOM 1A (a Doppler-based hemodynamic monitor that measures cardiac output across aortic or pulmonary valves and works regardless of patient rhythm or ventilation status), the BP+ (a central blood pressure monitor using patent-protected suprasystolic oscillometry to directly measure aortic pressure waveforms), and the SpiroSonic Suite (digital multi-path ultrasonic spirometers with no moving parts, no proprietary disposables, and Bluetooth/cloud connectivity). Companion software platforms (BP+ Reporter and SpiroReporter) provide data archiving, waveform analysis, and reporting functionality, with HL7-compliant EMR integration available on the USCOM 1A.

Uscom operates a distributor-led go-to-market model through approximately 35 regional distributors across 50+ countries, anchored by wholly-owned regional subsidiaries in Beijing (China), Budapest (Europe), and Singapore (SE Asia). Revenue is generated primarily through hardware sales of medical devices, supplemented by companion software and recurring distributor stocking orders. The company holds multiple regulatory approvals including CE Mark (BP+), FDA (USCOM 1A), CFDA (USCOM 1A), TGA ARTG (SpiroSonic), and US GSA Schedule listing for federal/VA/state government sales. Target clinical segments include critical care/ICU, hypertension and heart failure management, pulmonary/respiratory care, maternal medicine, and pediatric/neonatal care, with named deployments including the US Naval Base San Diego, US Veterans Affairs Medical Centers, the Public Health Agency of Catalonia, and Aqsitania SAS for French lung transplant monitoring. The business is supported by over 500 peer-reviewed clinical publications validating USCOM 1A clinical utility and is pursuing further geographic and product-line expansion via a Foxconn manufacturing partnership in China, an Eurostars-funded smart spacer development program, and new USCOM Basic/Classic/Advance variants tailored for Chinese market tendering.

Short descriptiontext

Uscom Limited (ASX: UCM) is an Australian medical technology company that develops and globally distributes non-invasive cardiovascular and pulmonary monitoring devices (USCOM 1A, BP+, SpiroSonic) via approximately 35 regional distributors serving critical care, hypertension, and respiratory clinical segments across 50+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
non-invasive hemodynamic monitoring, cardiac output monitoring devices, central blood pressure monitors, digital ultrasonic spirometry, medical Doppler devices
Industry5 codes
PRIMARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYCRACAQAF
Pulse Oximeters & Respiratory Monitors (Consumer)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Non-invasive Cardiovascular & Pulmonary Monitoring Devices
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of USCOM 1A hemodynamic monitors, BP+ central blood pressure monitors, and SpiroSonic spirometers. Products sold through distributor network globally. Multiple regulatory approvals (CE, FDA, CFDA, TGA) enabling sales in various jurisdictions.

uscom.com.au
2Software Solutions
TypeHardware Sales
Description

Companion software including BP+ Reporter for archiving, analysis and reporting, and SpiroReporter for pulmonary function data management.

uscom.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations
Pricing details1 tier
1Government Sales (GSA)
ModelOtherBilling cadenceMulti-year contract
Notes

GSA Schedule listing enables sales to US Federal Government, Veterans Affairs, and State/Local Governments at standardized pricing terms.

uscom.com.au
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Uscom designs, manufactures, and globally distributes three suites of non-invasive premium medical monitoring devices: the USCOM 1A Doppler-based cardiac output and hemodynamic monitor; the BP+ suprasystolic oscillometric central blood pressure monitor; and the SpiroSonic family of digital multi-path ultrasonic spirometers. Products are sold to hospitals, clinics, government health systems, and home-care programs through a network of approximately 35 regional medical device distributors across 50+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 95% appropriate fluid use vs 50% baseline when using USCOM 1A for fluid management
+4 more records
Product overview1 text field

Uscom is an Australian medical technology company specializing in non-invasive cardiovascular and pulmonary monitoring devices. The company offers three core product suites: the USCOM 1A advanced hemodynamic monitor (Doppler-based cardiac output monitoring), the BP+ central blood pressure monitor (suprasystolic oscillometric technology with companion BP+ Reporter software), and the SpiroSonic Suite of digital multi-path ultrasonic spirometers (with FLO, AIR, SMART variants and SpiroReporter software). Additional sub-products include USCOM Basic, Classic, and Advance variants developed for the Chinese market. These premium devices are designed for clinical and home care settings, focusing on cardiovascular disease, hypertension, heart failure, sepsis management, and pulmonary conditions including asthma, COPD, and sleep disorders.

Product and service5 records
1USCOM 1A
CategoryHemodynamic monitoring device
Description

Advanced non-invasive hemodynamic monitor using Doppler technology to measure cardiac blood flow, stroke volume, and cardiac output across the aortic or pulmonary valve. Used in sepsis, heart failure, hypertension, and fluid management across neonatal, pediatric, critical care, emergency, perioperative, oncological, maternal, and perinatal populations.

2BP+
CategoryCentral blood pressure monitor
Description

Non-invasive central blood pressure monitor using suprasystolic oscillometry to measure BP and pulse pressure waves directly at the heart (central BP) and in the arm. Performs Pulse Waveform Analysis (PWA), measures arterial stiffness, augmentation index, and pulse rate variability. Used in hypertension, heart failure, vascular health, and critical care.

3SpiroSonic Suite
CategoryDigital ultrasonic spirometer
Description

Digital multi-path ultrasonic spirometers (FLO, AIR, SMART variants) for pulmonary function testing using high-fidelity multi-path ultrasound. Requires no daily calibration, has no moving parts, and uses no proprietary disposables. Features Bluetooth connectivity, automated interpretation, and diagnostic decision support.

4SpiroSonic tSpiro
CategoryTelemetric spirometer
Description

Advanced multi-path ultrasonic spirometer with telemetric wireless connectivity for remote digital monitoring and cloud-based pulmonary function analysis, designed for home care and remote patient monitoring.

5USCOM Basic
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Manufacturing and R&D partnership in Beijing for USCOM devices. New facilities completed with NMPA regulatory requirements progressing. New devices USCOM Basic, Classic, and Advance developed for Chinese market to address 'Made in China by 2025' regulation requiring local manufacturing.

2CIIC Shanghai Science and Technology
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Chinese state-owned importation and wholesale partner for Uscom devices into China market. Responsible for CFDA regulatory process and distribution through Sense Medical network across 32 provinces.

uscom.com.au
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Master medical device distributor for SE Asia covering Thailand, Hong Kong, Macau, Singapore, Taiwan, Malaysia, and Indonesia. Long-term Uscom partner since USCOM 1A release. 3-year distribution agreement for BP+ and BP+ Reporter with ~AU$1.5M revenue target over 3 years.

4Mr Ng Jih Nang
Strategic tierCoreTypeOthers
Description

SE Asian Distribution and Business Development Manager with 20+ years Asian medical technology sales and BD experience with GE, Leica, Philips, Teleflex. Based in new Singapore Regional HQ covering ASEAN, Japan, South Korea, China, and Indian subcontinent.

uscom.com.au
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

French eHealth company partnership for lung transplant monitoring using ~100 SpiroSonic tSpiro devices. Second phase anticipated to order several hundred devices. Supported by European Union funding.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Spanish digital health partnership with Public Health Agency of Catalonia and University of Barcelona Health Campus. Nextcare Digital Health Care Project delivering telemetric pulmonary care using SpiroSonic tSpiro devices. First worldwide implementation of telemetric pulmonary care in eHealth home care model.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

European research grant consortium awarded 1,317,502 Euro (~AU$1.86M) over 2 years for smart spacer development. Uscom receiving 349,480 Euro (~AU$492k) for pulmonary recovery training and drug uptake research. Collaboration with Dutch pulmonary specialists.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1nSpire Health
TypeDirect peer
Description

nSpire Health is a specialist manufacturer of pulmonary function testing and spirometry equipment and competes head-to-head with Uscom's SpiroSonic suite across clinical and research spirometry use cases.

TypeBroad incumbent
Description

Philips is a broad incumbent in multi-parameter patient monitoring (IntelliVue) and EMR-integrated vital-signs platforms; while not specialized in Uscom's specific Doppler/oscillometry niches, its enterprise monitoring strategy competes for the same hospital capital budget and clinician mindshare.

3AtCor Medical (now CardieX / SphygmoCor)
TypeDirect peer
Description

AtCor Medical's SphygmoCor is the historical gold-standard device for non-invasive central aortic blood pressure measurement and the most direct competitor to Uscom's BP+ in the central blood pressure and pulse-wave-analysis category.

4Dräger
TypeBroad incumbent
Description

Dräger's Infinity and Perseus patient monitoring platforms are established incumbents in critical-care monitoring and anesthesia, with overlapping hemodynamic and respiratory monitoring positioning that competes for ICU and OR placements against Uscom.

TypeBroad incumbent
Description

Masimo is a broad incumbent in non-invasive patient monitoring (pulse oximetry, rainbow SET, and connected bedside monitoring) and competes with Uscom's vital signs monitoring and EMR-connected device philosophy via its hospital automation and tele-monitoring offerings.

TypeDirect peer
Description

Edwards Lifesciences is the dominant player in invasive and minimally invasive hemodynamic monitoring through its FloTrac/Vigileo, ClearSight, and VolumeView platforms and is the most direct competitor to Uscom's USCOM 1A Doppler-based cardiac output monitor. Both companies target ICU, OR, and ED fluid management and sepsis protocols.

TypeDirect peer
Description

Cheetah Medical (acquired by Baxter) commercializes the NICOM non-invasive cardiac output monitor using bioreactance technology — a direct competitive alternative to USCOM 1A for non-invasive hemodynamic monitoring in critical care environments.

TypeEmerging player
Description

Mindray is a China-headquartered emerging global player in patient monitoring, in-vitro diagnostics, and medical imaging; it is the most direct local competitor inside China and increasingly competes in emerging markets where Uscom distributes through Sense Medical and CIIC.

TypeBroad incumbent
Description

GE Healthcare's CARESCAPE patient monitoring platform addresses the same critical-care hemodynamic and respiratory monitoring use cases as Uscom's USCOM 1A and SpiroSonic, and benefits from broad multi-modality enterprise sales coverage.

10Nihon Kohden
TypeBroad incumbent
Description

Nihon Kohden is a broad incumbent in multi-parameter bedside patient monitoring, neurology, and cardiology, with established hemodynamic and respiratory monitoring offerings that overlap with Uscom's USCOM 1A and SpiroSonic portfolios across Asian hospital accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Uscom

Non-invasive Cardiovascular & Pulmonary Monitoring Devicesuscom.com.au

Uscom Limited (ASX: UCM) is an Australian medical technology company that develops and globally distributes non-invasive cardiovascular and pulmonary monitoring devices (USCOM 1A, BP+, SpiroSonic) via approximately 35 regional distributors serving critical care, hypertension, and respiratory clinical segments across 50+ countries.

What Uscom does

Uscom Limited (ASX: UCM) is an Australian medical technology company founded in 1999 and headquartered in Sydney that develops, manufactures, and globally markets non-invasive cardiovascular and pulmonary monitoring devices. The company's three core product suites are the USCOM 1A (a Doppler-based hemodynamic monitor that measures cardiac output across aortic or pulmonary valves and works regardless of patient rhythm or ventilation status), the BP+ (a central blood pressure monitor using patent-protected suprasystolic oscillometry to directly measure aortic pressure waveforms), and the SpiroSonic Suite (digital multi-path ultrasonic spirometers with no moving parts, no proprietary disposables, and Bluetooth/cloud connectivity). Companion software platforms (BP+ Reporter and SpiroReporter) provide data archiving, waveform analysis, and reporting functionality, with HL7-compliant EMR integration available on the USCOM 1A.

Uscom operates a distributor-led go-to-market model through approximately 35 regional distributors across 50+ countries, anchored by wholly-owned regional subsidiaries in Beijing (China), Budapest (Europe), and Singapore (SE Asia). Revenue is generated primarily through hardware sales of medical devices, supplemented by companion software and recurring distributor stocking orders. The company holds multiple regulatory approvals including CE Mark (BP+), FDA (USCOM 1A), CFDA (USCOM 1A), TGA ARTG (SpiroSonic), and US GSA Schedule listing for federal/VA/state government sales. Target clinical segments include critical care/ICU, hypertension and heart failure management, pulmonary/respiratory care, maternal medicine, and pediatric/neonatal care, with named deployments including the US Naval Base San Diego, US Veterans Affairs Medical Centers, the Public Health Agency of Catalonia, and Aqsitania SAS for French lung transplant monitoring. The business is supported by over 500 peer-reviewed clinical publications validating USCOM 1A clinical utility and is pursuing further geographic and product-line expansion via a Foxconn manufacturing partnership in China, an Eurostars-funded smart spacer development program, and new USCOM Basic/Classic/Advance variants tailored for Chinese market tendering.

Uscom firmographics

Firmographics
Name
Uscom
Legal name
Uscom Limited
Website
https://uscom.com.au
Company type
Public
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
Uscom Limited (ASX: UCM) is an Australian medical technology company that develops and globally distributes non-invasive cardiovascular and pulmonary monitoring devices (USCOM 1A, BP+, SpiroSonic) via approximately 35 regional distributors serving critical care, hypertension, and respiratory clinical segments across 50+ countries.
Ownership category
akta.pro rank

Uscom industry classification

Industry
Product category
Non-invasive Cardiovascular & Pulmonary Monitoring Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYCRACAQAF
Pulse Oximeters & Respiratory Monitors (Consumer)
Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

  • Non-invasive hemodynamic monitoring
  • Cardiac output monitoring devices
  • Central blood pressure monitors
  • Digital ultrasonic spirometry
  • Medical Doppler devices

Where Uscom is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

Uscom business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations

Revenue model

  1. Medical Device Sales: Sale of USCOM 1A hemodynamic monitors, BP+ central blood pressure monitors, and SpiroSonic spirometers. Products sold through distributor network globally. Multiple regulatory approvals (CE, FDA, CFDA, TGA) enabling sales in various jurisdictions.
  2. Software Solutions: Companion software including BP+ Reporter for archiving, analysis and reporting, and SpiroReporter for pulmonary function data management.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractGovernment Sales (GSA)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Uscom product offering

Product offering

Core offering

Uscom designs, manufactures, and globally distributes three suites of non-invasive premium medical monitoring devices: the USCOM 1A Doppler-based cardiac output and hemodynamic monitor; the BP+ suprasystolic oscillometric central blood pressure monitor; and the SpiroSonic family of digital multi-path ultrasonic spirometers. Products are sold to hospitals, clinics, government health systems, and home-care programs through a network of approximately 35 regional medical device distributors across 50+ countries.

Product overview

Uscom is an Australian medical technology company specializing in non-invasive cardiovascular and pulmonary monitoring devices. The company offers three core product suites: the USCOM 1A advanced hemodynamic monitor (Doppler-based cardiac output monitoring), the BP+ central blood pressure monitor (suprasystolic oscillometric technology with companion BP+ Reporter software), and the SpiroSonic Suite of digital multi-path ultrasonic spirometers (with FLO, AIR, SMART variants and SpiroReporter software). Additional sub-products include USCOM Basic, Classic, and Advance variants developed for the Chinese market. These premium devices are designed for clinical and home care settings, focusing on cardiovascular disease, hypertension, heart failure, sepsis management, and pulmonary conditions including asthma, COPD, and sleep disorders.

Differentiator

Problem solved

Functional benefit

Products and services

  • USCOM 1A Advanced non-invasive hemodynamic monitor using Doppler technology to measure cardiac blood flow, stroke volume, and cardiac output across the aortic or pulmonary valve. Used in sepsis, heart failure, hypertension, and fluid management across neonatal, pediatric, critical care, emergency, perioperative, oncological, maternal, and perinatal populations.
  • BP+ Non-invasive central blood pressure monitor using suprasystolic oscillometry to measure BP and pulse pressure waves directly at the heart (central BP) and in the arm. Performs Pulse Waveform Analysis (PWA), measures arterial stiffness, augmentation index, and pulse rate variability. Used in hypertension, heart failure, vascular health, and critical care.
  • SpiroSonic Suite Digital multi-path ultrasonic spirometers (FLO, AIR, SMART variants) for pulmonary function testing using high-fidelity multi-path ultrasound. Requires no daily calibration, has no moving parts, and uses no proprietary disposables. Features Bluetooth connectivity, automated interpretation, and diagnostic decision support.
  • SpiroSonic tSpiro Advanced multi-path ultrasonic spirometer with telemetric wireless connectivity for remote digital monitoring and cloud-based pulmonary function analysis, designed for home care and remote patient monitoring.
  • USCOM Basic

Quantifiable outcome

  • 95% appropriate fluid use vs 50% baseline when using USCOM 1A for fluid management
  • +4 more outcomes

Companies that use Uscom

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Uscom technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Uscom partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and strategic.

  • Foxconn (Beijing)coreStrategic or Co-development Partner · 1 January 2022Manufacturing and R&D partnership in Beijing for USCOM devices. New facilities completed with NMPA regulatory requirements progressing. New devices USCOM Basic, Classic, and Advance developed for Chinese market to address 'Made in China by 2025' regulation requiring local manufacturing.
  • CIIC Shanghai Science and TechnologycoreChannel Partner/ Reseller/ DistributorChinese state-owned importation and wholesale partner for Uscom devices into China market. Responsible for CFDA regulatory process and distribution through Sense Medical network across 32 provinces.
  • Pacific Medical Systems (PMS)coreChannel Partner/ Reseller/ DistributorMaster medical device distributor for SE Asia covering Thailand, Hong Kong, Macau, Singapore, Taiwan, Malaysia, and Indonesia. Long-term Uscom partner since USCOM 1A release. 3-year distribution agreement for BP+ and BP+ Reporter with ~AU$1.5M revenue target over 3 years.
  • Mr Ng Jih NangcoreOthersSE Asian Distribution and Business Development Manager with 20+ years Asian medical technology sales and BD experience with GE, Leica, Philips, Teleflex. Based in new Singapore Regional HQ covering ASEAN, Japan, South Korea, China, and Indian subcontinent.
  • Aqsitania SASstrategicStrategic or Co-development PartnerFrench eHealth company partnership for lung transplant monitoring using ~100 SpiroSonic tSpiro devices. Second phase anticipated to order several hundred devices. Supported by European Union funding.
  • Sonmedica S.A.strategicStrategic or Co-development PartnerSpanish digital health partnership with Public Health Agency of Catalonia and University of Barcelona Health Campus. Nextcare Digital Health Care Project delivering telemetric pulmonary care using SpiroSonic tSpiro devices. First worldwide implementation of telemetric pulmonary care in eHealth home care model.
  • Eurostars ProgrammestrategicStrategic or Co-development PartnerEuropean research grant consortium awarded 1,317,502 Euro (~AU$1.86M) over 2 years for smart spacer development. Uscom receiving 349,480 Euro (~AU$492k) for pulmonary recovery training and drug uptake research. Collaboration with Dutch pulmonary specialists.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Uscom competitors and assessment

Company assessment

Direct peers

  • nSpire Health: nSpire Health is a specialist manufacturer of pulmonary function testing and spirometry equipment and competes head-to-head with Uscom's SpiroSonic suite across clinical and research spirometry use cases.
  • AtCor Medical (now CardieX / SphygmoCor): AtCor Medical's SphygmoCor is the historical gold-standard device for non-invasive central aortic blood pressure measurement and the most direct competitor to Uscom's BP+ in the central blood pressure and pulse-wave-analysis category.
  • Edwards Lifesciences: Edwards Lifesciences is the dominant player in invasive and minimally invasive hemodynamic monitoring through its FloTrac/Vigileo, ClearSight, and VolumeView platforms and is the most direct competitor to Uscom's USCOM 1A Doppler-based cardiac output monitor. Both companies target ICU, OR, and ED fluid management and sepsis protocols.
  • Cheetah Medical: Cheetah Medical (acquired by Baxter) commercializes the NICOM non-invasive cardiac output monitor using bioreactance technology — a direct competitive alternative to USCOM 1A for non-invasive hemodynamic monitoring in critical care environments.

Broad incumbents

  • Philips Healthcare: Philips is a broad incumbent in multi-parameter patient monitoring (IntelliVue) and EMR-integrated vital-signs platforms; while not specialized in Uscom's specific Doppler/oscillometry niches, its enterprise monitoring strategy competes for the same hospital capital budget and clinician mindshare.
  • Dräger: Dräger's Infinity and Perseus patient monitoring platforms are established incumbents in critical-care monitoring and anesthesia, with overlapping hemodynamic and respiratory monitoring positioning that competes for ICU and OR placements against Uscom.
  • Masimo: Masimo is a broad incumbent in non-invasive patient monitoring (pulse oximetry, rainbow SET, and connected bedside monitoring) and competes with Uscom's vital signs monitoring and EMR-connected device philosophy via its hospital automation and tele-monitoring offerings.
  • GE Healthcare: GE Healthcare's CARESCAPE patient monitoring platform addresses the same critical-care hemodynamic and respiratory monitoring use cases as Uscom's USCOM 1A and SpiroSonic, and benefits from broad multi-modality enterprise sales coverage.
  • Nihon Kohden: Nihon Kohden is a broad incumbent in multi-parameter bedside patient monitoring, neurology, and cardiology, with established hemodynamic and respiratory monitoring offerings that overlap with Uscom's USCOM 1A and SpiroSonic portfolios across Asian hospital accounts.

Emerging players

  • Mindray: Mindray is a China-headquartered emerging global player in patient monitoring, in-vitro diagnostics, and medical imaging; it is the most direct local competitor inside China and increasingly competes in emerging markets where Uscom distributes through Sense Medical and CIIC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Uscom social profiles

Digital presence

Uscom compliance and trust

Trust signal

Compliance6 records

Uscom financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Uscom leadership team

Management profile

Number of profiles

Profiles6 records

Uscom subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Uscom funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Uscom M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Uscom

What does Uscom do?

Uscom designs, manufactures, and globally distributes three suites of non-invasive premium medical monitoring devices: the USCOM 1A Doppler-based cardiac output and hemodynamic monitor; the BP+ suprasystolic oscillometric central blood pressure monitor; and the SpiroSonic family of digital multi-path ultrasonic spirometers. Products are sold to hospitals, clinics, government health systems, and home-care programs through a network of approximately 35 regional medical device distributors across 50+ countries.

Is Uscom a public or private company?

Uscom is a public company. It is classified as public and is currently operating.

When was Uscom founded?

Uscom was founded in 1999. It employs 11 to 50 people.

Where is Uscom based?

Uscom is headquartered in Sydney, Australia, in the Oceania region.

How does Uscom make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are software Solutions.

Who are Uscom's main competitors?

Direct peers on record are nSpire Health, AtCor Medical (now CardieX / SphygmoCor), Edwards Lifesciences and Cheetah Medical. Broad incumbents are Philips Healthcare, Dräger, Masimo, GE Healthcare and Nihon Kohden. Mindray is listed as an emerging player.

Does Uscom have an API?

No public API is recorded for Uscom.

What industry is Uscom in?

Uscom's product category is Non-invasive Cardiovascular & Pulmonary Monitoring Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals